The Protective Effect of Cordymin, a Peptide Purified from the Medicinal MushroomCordyceps sinensis, on Diabetic Osteopenia in Alloxan-Induced Diabetic Rats
Author(s) -
Qi Wei,
Yang Zhang,
YaBo Yan,
Wei Lei,
Zixiang Wu,
Ning Liu,
Shuai Liu,
Lei Shi,
Yong Fan
Publication year - 2013
Publication title -
evidence-based complementary and alternative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.552
H-Index - 90
eISSN - 1741-4288
pISSN - 1741-427X
DOI - 10.1155/2013/985636
Subject(s) - osteopenia , alloxan , medicine , diabetes mellitus , endocrinology , antioxidant , bone mineral , osteoporosis , alkaline phosphatase , intraperitoneal injection , chemistry , biochemistry , enzyme
The aim of this study was to investigate the protective effect of cordymin on diabetic osteopenia in alloxan-induced diabetic rats and the possible mechanisms involved. The diabetic rats received daily intraperitoneal injection with cordymin (20, 50, and 100 mg/kg/day) for 5 weeks. Cordymin could restore the circulating blood glucose, glycosylated hemoglobin (HbA1c), serum alkaline phosphatase (ALP), tartrate resistant acid phosphatase (TRAP), and insulin levels in a dose-dependent manner. Also, the treatment of diabetic rats with cordymin could partially reverse the β cells death and decrease the total antioxidant status (TAOS) in the diabetic rats. The results may directly and indirectly account for the possible mechanism of the beneficial effect of cordymin on diabetic osteopenia, which was confirmed with the increased bone mineral content (BMC) and bone mineral density (BMD) in diabetic rats ( P < 0.05). All those findings indicate that cordymin may play a protective role in diabetic osteoporosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom